IPG Photonics reports Q3 2026 results with double‑digit growth and announces Lumibird Medical acquisition

IPG Photonics posted Q3 2026 revenue of $287.5 million, a 15% year‑over‑year increase, and adjusted earnings per share of $0.61. Advanced Solutions revenue rose 33% YoY, driven by semiconductor and defense sales, while Industrial Solutions grew 12% YoY. The company guided Q4 2026 revenue to $265 million‑$295 million and said its pending acquisition of Lumibird Medical, valued at €300 million, is expected to close in the fourth quarter.

The earnings beat and strong cash position of $926 million give the company flexibility for strategic investments, but the lower‑end Q4 revenue guidance signals a near‑term slowdown. The Lumibird Medical deal expands IPG’s medical laser platform, potentially adding a $2 billion addressable market.

Sources